What is Twin Health?
AI digital-twin platform for metabolic disease reversal and prevention.
- Category
- Metabolic health
- Headquarters
- Mountain View, CA
- Founded
- 2018
- Employees
- About 600 reported
- Total funding
- $272M reported
- Valuation
- $950M+ Series E valuation
What is Twin Health?
Twin Health is a metabolic health company. Twin works with employers and health plans on diabetes, obesity, and metabolic health programs using connected devices and AI-guided coaching.
Twin Health is a metabolic health company with headquarters listed as Mountain View, CA. AI digital-twin platform for metabolic disease reversal and prevention. Twin works with employers and health plans on diabetes, obesity, and metabolic health programs using connected devices and AI-guided coaching.
The company is currently best read as Private; Series E. Public sources show $272M reported in funding and $950M+ Series E valuation; where revenue, ARR, margin, or exact customer counts are not published, this profile avoids inventing them and uses funding, footprint, product coverage, and public scale signals instead.
For sellers, the account matters because buying centers span clinical operations, compliance, product, data, security, finance, and growth. The strongest pitch is tied to measurable access, quality, cost, workflow, or workforce outcomes rather than generic software adoption.
What does Twin Health offer?
Twin Health offers Whole Body Digital Twin, Diabetes reversal program, Obesity care, GLP-1 strategy support, and related workflows.
- Whole Body Digital Twin· Core product
- Diabetes reversal program· Core product
- Obesity care· Care workflow
- GLP-1 strategy support· Care workflow
- Connected-device biomarker tracking· Expansion
- Health-plan and employer programs· Expansion
How does Twin Health make money?
Twin sells care programs to employers, payers, and risk-bearing partners that want measurable metabolic outcomes and lower drug or complication costs.
Twin sells care programs to employers, payers, and risk-bearing partners that want measurable metabolic outcomes and lower drug or complication costs.
Pricing is not published; contracts are outcome, program, or population-health arrangements rather than a public consumer subscription. Growth is driven by adoption in metabolic health, expansion into larger accounts or additional geographies, and proof that the product improves outcomes, cost, capacity, or experience.
Because the company is private, this profile does not invent revenue, gross margin, or unit economics. Sellers should qualify budget owner, reimbursement model, procurement path, compliance requirements, and integration effort early.
Who leads Twin Health?
Twin Health is led by Jahangir Mohammed, Terry Poon, Maluk Mohamed, Lisa Shah, MD.
- Jahangir MohammedFounder & CEOFounderSerial entrepreneur and former Jasper Technologies CEO.
- Terry PoonCo-founder, EVP & CTOFounderLeads digital-twin technology and algorithms.
- Maluk MohamedCo-founder & VP ResearchFounderLeads research behind the metabolic digital twin.
- Lisa Shah, MDEVP & Chief Medical OfficerCurrent executiveLeads clinical operations and medical strategy.
How do you contact Twin Health's leadership?
Twin Health does not publish verified personal executive emails in the reviewed public sources. Use official company contact, demo, support, partnerships, or careers routes rather than guessed personal emails.
Personal executive email format not verified; use official company routingHow much funding has Twin Health raised?
Twin Health has $272M reported in public or reported funding; latest disclosed round: Sep 2025 Series E ($53M).
Twin Health's disclosed funding history is: 2018 Seed/early: undisclosed, valuation not disclosed, led/backed by early investors; Oct 2021 Series C: $140M, valuation not disclosed, led/backed by Sequoia Capital India; 2022-2024 Growth rounds: additional capital, valuation not disclosed, led/backed by Temasek, ICONIQ, Sofina, and others reported; Sep 2025 Series E: $53M, $950M+ valuation, led/backed by Maj Invest.
The latest public valuation/status used here is $950M+ Series E valuation. If a valuation is not disclosed, this profile treats the company as private with no public priced mark rather than inferring a number from round size.
Seller signal: funding indicates capacity to invest, but healthcare buyers still require security, compliance, implementation proof, and outcomes evidence. New capital is most likely to support market expansion, hiring, product development, clinical operations, data, AI, and partnerships.
How did Twin Health get here?
Twin Health reached its current stage through founding, product expansion, and major financing milestones.
- 2018FoundedTwin Health launches to apply digital-twin technology to metabolic health.
- 2021$140M Series CTwin raises a large Sequoia-led round to scale diabetes reversal.
- 2025$53M Series ETwin raises new capital led by Maj Invest at a near-unicorn valuation.
- 2026Duke-Margolis framework featureTwin is highlighted in a private-investment healthcare value framework.
- 2026Metabolic-health expansionTwin keeps positioning around responsible GLP-1 strategies and root-cause metabolic care.
Who are Twin Health's competitors?
Twin Health competes with adjacent healthcare providers, software platforms, marketplaces, and care-navigation companies.
- Virta HealthEvidence-backed diabetes reversal and metabolic care provider.
- Omada HealthPublic digital chronic-care company for diabetes and cardiometabolic conditions.
- Vida HealthVirtual cardiometabolic and mental-health care platform.
- Lark HealthAI coaching for chronic conditions and prevention.
- CalibrateObesity and metabolic-health program built around GLP-1 care.
Twin Health — frequently asked questions
